reason report
bottom line maintain mp rate pt
lower estim post ebitda miss driven weaker uk
perform us ss revenu growth continu
peer driven de novo bed add uk ss ebitda margin
bp increas pressur staf shortag premium
agenc pay adequ censu stabil headwind
staf pressur expect continu though censu
could increas recent bed add us ss growth continu
impress driven bed add de novo ramp
expect continu drive near-term growth regulatori issu
held admiss resolv subpoena us
district wv relat fals claim investig comprehens
treatment center wv announc close file
could lead increas regulatori scrutini along recent short
lever may limit access capit de novo large-
scale without share rais rise interest rate headwind
continu specul pe takeout rang
link lower ebitda mm
ebitda mm
continu specul pe takeout
rang privat equiti pe alway interest given
addict treatment center acquir health outpati
focu eat disord substanc abus estim pe
could potenti spin uk busi via sale uk list
report ebitda miss in-lin revenu driven
uk staf shortag higher agenc cost censu
abl off-set higher wage revenu mm line
consensu adj ebitda mm expect
ebitda margin declin bp yoy bp qoq exhibit
ebitda guidanc lower due uk staf
censu headwind new ebitda guidanc midpoint
mm vs consensu estim mm time
ev/ebitda
net debt total capit
price-to-earnings lt ep growth
estimate lt ep growth lt ep compound-annual-growth-rate
compani inform leerink partner llc research
revenu million
pleas refer page import disclosur price chart analyst certif
uk ss ebitda margin bp increas
pressur staf shortag premium agenc pay
adequ censu stabil headwind believ
see stabil censu ramp uk bed
add season believ lose share though
nh may hold referr longer system
reach still staf pressur appear remain hope hire
nurs commonwealth nation appear stall due
uk headwind persist may seek altern
close tri divest certain facil view larg
divestitur uk possibl note nurs agenc
headwind driven larg facil uk
us segment ss revenu trend solid
acceler qoq yoy beat expect ss
ebitda margin bp us segment continu
outperform peer op revenu growth driven bed add
bed mix chang acut bed us continu impact length
stay lo us wage appear rel stabl
rang exhibit
lower estim lower ebitda
mm mm ebitda mm
mm reflect lower guidanc staf censu headwind
uk exhibit
continu enter jv open de novo add bed
us drive growth de novo typic ramp within month
take day facil goe line fulli
licens expect add bed ad
bed last month exhibit
compani remain lever may limit access
capit de novo large-scal without share rais
rise interest rate headwind intend reserv cash
acquir mission treatment nine comprehens treatment center
ca nv az ok whittier pavilion inpati psych
hospit haverhil term financi provid
subpoena announc post close along short-sel
report could add regulatori risk us announc
receiv subpoena us district wv relat fals
claim investig comprehens treatment center wv
investig relat variou document present
civil aspect investig focus certain lab servic
state cooper investig
maintain mp pt pt contempl
maintain mp pt lower estim post ebitda miss
driven weaker uk perform us ss revenu growth continu
peer driven de novo bed add
uk ss ebitda margin bp increas pressur staf shortag
premium agenc pay adequ censu stabil headwind staf
pressur expect continu though censu could increas recent bed
us ss growth continu impress driven bed add de novo ramp
expect continu drive near-term growth regulatori issu held
admiss resolv subpoena us district wv relat fals
claim investig comprehens treatment center wv announc close
file could lead increas regulatori scrutini along recent short sell report
compani remain lever may limit access capit de novo large-
scale without share rais rise interest rate headwind continu
specul pe takeout rang link lower ebitda
mm ebitda mm
continu specul pe takeout rang privat equiti pe
long interest given addict treatment center acquir
outpati focu eat disord substanc abus estim pe could
potenti spin uk busi via sale uk list
previou pe takeout note avail follow link link
report ebitda miss in-lin revenu driven uk staf shortag
higher agenc cost censu abl off-set higher wage revenu
mm line consensu adj ebitda mm expect
ebitda margin declin bp yoy bp qoq
report in-lin revenu ebitda ep miss driven uk staf pressur
ebitda guidanc lower due uk staf censu headwind new
ebitda guidanc midpoint mm vs consensu estim mm
time announc
revenu ebitda ep guidanc lower driven higher staf pressur censu
uk
uk ss ebitda margin bp increas pressur staf
shortag premium agenc pay adequ censu stabil
headwind believ see stabil censu ramp uk bed
add season believ lose share though nh may hold
referr longer system reach still staf pressur appear remain
hope hire nurs commonwealth nation appear stall due
compani guidanc compani guidanc compani guidanc compani guidanc inc
uk volum yoy qoq
uk headwind persist may seek altern close tri divest
certain facil view larg divestitur uk possibl note
nurs agenc headwind driven larg facil uk locat
us segment ss revenu trend solid acceler qoq yoy
beat expect ss ebitda margin bp us segment
continu outperform peer revenu growth driven bed add bed mix chang
acut bed us continu impact length stay lo us wage appear
rel stabl rang
us ss revenu trend acceler qoq yoy driven de novo bed add
us volum trend acceler qoq yoy season weak
ss price continu strong trend acceler yoy
lower estim lower ebitda mm
ebitda mm reflect lower guidanc staf censu headwind uk
lower ebitda reflect lower uk outlook
oper leas net per patient per patient acadia healthcar compani inc
lower ebitda mm mm
lower ebitda mm mm
leerink partner research estim note number may sum total due round
continu enter jv open de novo add bed us drive growth
de novo typic ramp within month take day facil goe
line fulli licens expect add bed ad bed
last month
driver leerink ss growth uk ss growth driven volum price includ gradual ramp imd exclus bed addsramp de de novo facil uk censu staf issu continu remain leerink leerink ss growth uk ss growth driven volum pricingramp de de novo facil expens bp improvementuk censu staf issu continu moder leerink acadia healthcar compani inc
expect open new jv around new de novo
compani remain lever may limit access capit de novo
large-scal without share rais rise interest rate headwind
intend reserv cash vs debt paydown sign definit agreement
acquir mission treatment nine comprehens treatment center ca nv az ok
whittier pavilion inpati psych hospit haverhil term financi
provid
subpoena announc post close along short-sel report could add
regulatori risk us announc receiv subpoena us district
wv relat fals claim investig comprehens treatment center wv
investig relat variou document present civil aspect
investig focus certain lab servic state cooper
maintain mp pt pt contempl ev/ebitda
trade ebitda consensu view
pt contempl ev/ebitda ebitda
primari valuat methodolog base ev/ebitda rel rel
ev/ebitda also track function compani histori hospit group
averag assess potenti ev/ebitda expans next month base
forward forecast contempl underli fundament implic healthcar
reform dcf valuat leverag forward forecast wacc termin
growth rate point potenti multipl expans along sector company-
specif catalyst expect greater potenti multipl expans dcf valuat point
significantli upsid peer current trade level base rate
market perform price target base ev/ebitda
adjust ebitda
downsid risk valuat includ
risk higher acquisit multipl slow acquisit driven growth
financi posit result oper
uk reli publicli fund entiti unit kingdom
revenu loss reduct fund chang procur method
primari valuat methodolog base rel ev/ebitda rel
ev/ebitda track function compani histori hospit group averag
assess potenti ev/ebitda expans next month base forward
forecast contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
point potenti multipl expans along sector compani specif
catalyst expect greater potenti multipl expans dcf valuat point
significantli upsid peer current trade level base rate
outperform price target base ev/ebitda
downsid risk valuat includ
possibl delay medicaid expans current non-expans state
acut care segment highli concentr la vega texa
cut govern commerci payer reimburs
declin receiv collect rate
pay mix pressur behavior segment
incom provis doubt net expensessalari rent leas oper ebitda depreci oper non-oper ebit net interest incom tax incom yoy net incom averag share million dilut dilut yoy non-recur item metricsrevenu growth expense/net leas expense/net opex/net debt/gross inc
hospit usinpati chang chang chang hospit ukinpati chang chang revenu chang acadia healthcar compani inc
